Stock Name | iShares Edge MSCI World Quality Factor UCITS ETF |
Issuer | Blackrock |
ETF Ticker | IWFQ(GBX) LSE |
ETF Ticker | IS3Q(EUR) F |
ETF Ticker | IS3Q.DE(EUR) CXE |
ETF Ticker | IWFQ.LS(GBX) CXE |
ETF Ticker | IWQU.LS(USD) CXE |
ETF Ticker | IWQU.MI(EUR) CXE |
ETF Ticker | IWQU(EUR) ETF Plus |
ETF Ticker | IWFQ.L(GBP) LSE |
Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
---|---|---|---|---|
VRTX - Vertex Pharmaceuticals Inc | SELL | -182 @ USD 421.15 | USD -76,649 | The ETF sold 182 shares of VRTX on 2025-10-08. The shares were previously bought for an average price of USD 454.219. The Vertex Pharmaceuticals Inc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,019 The average price that the ETF previously sold VRTX share for is USD 453.58 which is higher than the selling price of USD 421.15 on 2025-10-08. |
Value of shares added and average price calculated using the adjusted close on the day which may not be the price the ETF paid for the shares or sold the share at